Categorized, daily coverage of the biotech and pharma industry, straight to your inbox.
Trusted by 600+ biotech and pharma professionals.
“I’ve really enjoyed [the TLDR Biotech] updates - both the information they convey and how it’s conveyed. We do a lot of work in the CGT space and I like having [these] updates as a reminder for me to keep active in reading up on information.”
“What I appreciate about [the TLDR Biotech] newsletter is how easy to read it is. I really like that you don't write more than necessary about any of the news but rather provide links for further info. This way I definitely read it entirely and not stop halfway through.”
“I like the comprehensive and digestible style. Not just the good stuff, but the bad and the ugly too. And in a quick-to-read format. Nice to have in my inbox!”
“This is the first news letter I read almost daily and I personally find it super useful.”
“TLDR Biotech packs tons of useful information (good, bad, and ugly) into each daily newsletter. It's an easy, quick way to stay up to date on industry news, with links to more when you want to take a deep dive. I recommend it for staying on top of a rapidly changing industry as well as for business development fuel.”
“As a business developer in the drug discovery and preclinical field, staying updated is crucial. I highly recommend this biotech newsletter—it offers a well-curated selection of important developments, written in an engaging and fun way. It's the perfect way to break up my day while keeping me informed on the latest in the industry.”
“TLDR Biotech is my one-stop-shop for biotech industry news. This daily newsletter presents the most important stories of the day it in a cleaver, easy to understand way.”